Retour
Fourchette du Jour
51,64 €
55,00 €
Fourchette 52 Semaines
16,16 €
56,30 €
Volume
324 005
Moyenne 50J / 200J
47,29 €
/
38,36 €
Clôture Précédente
50,76 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 45,2 | 0,4 |
| P/B | 7,6 | 2,9 |
| ROE % | 17,8 | 3,8 |
| Net Margin % | 3,7 | 3,9 |
| Rev Growth 5Y % | 11,7 | 10,0 |
| D/E | 2,7 | 0,2 |
Objectif de Cours des Analystes
Hold
49,00 €
-8.9%
P/E Prévisionnel
17,8
BPA Prévisionnel
3,03 €
Croissance BPA (est.)
+0,0%
CA Est.
1,5 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
3,71 €
3,68 € – 3,74 €
|
1,6 B | 1 |
| FY2027 |
3,37 €
3,13 € – 3,54 €
|
1,5 B | 3 |
| FY2026 |
3,03 €
2,98 € – 3,07 €
|
1,5 B | 3 |
Points Clés
Revenue grew 11,68% annually over 5 years — strong growth
Earnings grew 1897,68% over the past year
ROE of 17,80% — decent returns on equity
Debt/Equity of 2,67 — high leverage
Generating 41,83M in free cash flow
P/E of 45,18 — premium valuation
Croissance
Revenue Growth (5Y)
11,68%
Revenue (1Y)27,37%
Earnings (1Y)1897,68%
FCF Growth (3Y)N/A
Qualité
Return on Equity
17,80%
ROIC7,91%
Net Margin3,72%
Op. Margin8,52%
Sécurité
Debt / Equity
2,67
Current Ratio2,76
Interest Coverage3,32
Valorisation
P/E Ratio
45,18
P/B Ratio7,63
EV/EBITDA26,02
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 27,37% | Revenue Growth (3Y) | 15,13% |
| Earnings Growth (1Y) | 1897,68% | Earnings Growth (3Y) | 21,66% |
| Revenue Growth (5Y) | 11,68% | Earnings Growth (5Y) | -2,94% |
| Profitability | |||
| Revenue (TTM) | 1,30B | Net Income (TTM) | 48,26M |
| ROE | 17,80% | ROA | 3,55% |
| Gross Margin | 30,85% | Operating Margin | 8,52% |
| Net Margin | 3,72% | Free Cash Flow (TTM) | 41,83M |
| ROIC | 7,91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,67 | Current Ratio | 2,76 |
| Interest Coverage | 3,32 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 45,18 | P/B Ratio | 7,63 |
| P/S Ratio | 1,68 | PEG Ratio | 0,01 |
| EV/EBITDA | 26,02 | Dividend Yield | 0,02% |
| Market Cap | 2,18B | Enterprise Value | 2,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,30B | 1,02B | 977,89M | 942,26M | 833,35M |
| Net Income | 48,26M | 2,42M | 32,61M | 49,18M | 54,39M |
| EPS (Diluted) | 1,19 | 0,06 | 0,81 | 1,21 | 1,34 |
| Gross Profit | 399,94M | 313,09M | 298,24M | 285,40M | 271,38M |
| Operating Income | 110,47M | 53,32M | 71,85M | 78,99M | 74,87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,36B | 982,18M | 971,40M | 931,70M | 841,33M |
| Total Liabilities | 1,08B | 725,54M | 688,89M | 669,26M | 602,80M |
| Shareholders' Equity | 285,68M | 256,64M | 282,51M | 262,44M | 238,53M |
| Total Debt | 761,55M | 525,46M | 509,97M | 470,48M | 426,71M |
| Cash & Equivalents | 68,04M | 70,61M | 41,28M | 74,25M | 50,21M |
| Current Assets | 810,61M | 601,00M | 585,72M | 566,23M | 498,91M |
| Current Liabilities | 293,47M | 204,15M | 176,00M | 190,83M | 164,12M |